Suchergebnisse - "Retz, Margitta"

PubPharm (225)

1

Pembrolizumab and Enzalutamide in Patients with Abiraterone Acetate-Pretreated Metastatic Castration-Resistant Prostate Cancer : Cohort C of the Phase 1b/2 KEYNOTE-365 Study

enthalten in: European urology oncology | 2023

von Yu, E. | Berry, W. | Gurney, H. | +17

2

Sequential therapy of advanced bladder cancer after prior perioperative systemic treatment : Recommendations from the Interdisciplinary Bladder Carcinoma Working Group (IABC) of the DKG e. V.

enthalten in: Urologie (Heidelberg, Germany) | 2023

von Retz, M. | Kirchhoff, F. | von Amsberg, G. | +4

3

Safety and Efficacy of [177Lu]-PSMA-I&T Radioligand Therapy in Octogenarians with Metastatic Castration-Resistant Prostate Cancer : Report on 80 Patients over the Age of 80 Years

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2023

von Tauber, R. | Knorr, K. | Retz, M. | +9

4

Adjuvant vs. progression-triggered treatment with gemcitabine in platinum-ineligible high-risk bladder cancer patients : Long-term follow-up of a randomized phase 3 trial

enthalten in: Urologic oncology | 2023

von Heinzelbecker, J. | Spieler, N. | Kuehn, M. | +17

5

Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer : The Randomized, Open-Label, Phase III KEYLYNK-010 Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Antonarakis, E. | Park, S. | Goh, J. | +28

6

Both radiographical and pathological lymph node statuses are independent predictors for survival following neoadjuvant chemotherapy and radical cystectomy for cT3/4 or cN+ bladder cancer

enthalten in: World journal of urology | 2023

von Wagner, J. | Simon, R. | Büchler, J. | +6

7

Das metastasierte Urothelkarzinom – leitlinienorientierte Therapie und neue Optionen

enthalten in: Journal für Urologie und Urogynäkologie / Österreich | 2022

von Niegisch, G. | von Amsberg, G. | Rehlinghaus, M. | +2

8

Das metastasierte Urothelkarzinom – leitlinienorientierte Therapie und neue Optionen

enthalten in: Journal für Urologie und Urogynäkologie / Österreich | 2022

von Niegisch, G. | von Amsberg, G. | Rehlinghaus, M. | +2

9

Both radiographical and pathological lymph node statuses are independent predictors for survival following neoadjuvant chemotherapy and radical cystectomy for cT3/4 or cN+ bladder cancer

enthalten in: World journal of urology | 2022

von Wagner, J. | Simon, R. | Büchler, J. | +6

10

Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer : results from the phase 2 CheckMate 9KD trial

enthalten in: Journal for immunotherapy of cancer | 2022

von Fizazi, K. | Retz, M. | Petrylak, D. | +24

CommentIn: J Urol. 2023 Apr;209(4):807-809. - PMID 36695094

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]